Norwegian Ministry of Health and Care Services. Principles for priority setting in health care— summary of a white paper on priority setting in the Norwegian health care sector (2017). https://www.regjeringen.no/contentassets/439a420e01914a18b21f351143ccc6af/en-gb/pdfs/stm201520160034000engpdfs.pdf

Statens Legemiddelverk (2018). Guidelines for the submission of documentation for single technology assessment (STA) of pharmaceuticals. https://legemiddelverket.no/english/public-funding-and-pricing/documentation-for-sta/guidelines-for-the-submission-of-documentation-for-single-technology-assessment-sta-of-pharmaceuticals. Accessed 12 December 2023.

Roudijk, B., Ludwig, K., & Devlin, N. (2022). EQ-5D-5L value set summaries. In N. Devlin, B. Roudijk, & K. Ludwig (Eds.), Value sets for EQ-5D-5L. Springer. https://doi.org/10.1007/978-3-030-89289-0_4

Poudel, N., Fahim, S. M., Qian, J., Garza, K., Chaiyakunapruk, N., & Ngorsuraches, S. (2022). Methodological similarities and variations among EQ-5D-5L value set studies: A systematic review. Journal of Medical Economics, 25(1), 571–582. https://doi.org/10.1080/13696998.2022.2066441

Article  CAS  PubMed  Google Scholar 

Teni, F. S., Rolfson, O., Devlin, N., Parkin, D., Nauclér, E., Burström, K., & Swedish Quality Register (SWEQR) Study Group. (2022). Longitudinal study of patients’ health-related quality of life using EQ-5D-3L in 11 Swedish National Quality registers. British Medical Journal Open, 12(1), e048176. https://doi.org/10.1136/bmjopen-2020-048176

Article  Google Scholar 

Garratt, A. M., Engen, K., Kjeldberg, I. R., Nordvik, J. E., Ringheim, I., Westskogen, L., & Becker, F. (2023). Use of EQ-5D-5L for assessing patient-reported outcomes in a National Register for Specialized Rehabilitation. Archives of Physical Medicine and Rehabilitation, S0003-9993(23), 00304–00300. https://doi.org/10.1016/j.apmr.2023.04.026. Advance online publication.

Article  Google Scholar 

Bouckaert, N., Cleemput, I., Devriese, S., & Gerkens, S. (2022). An EQ-5D-5L Value Set for Belgium. PharmacoEconomics - Open, 6(6), 823–836. https://doi.org/10.1007/s41669-022-00353-37

Article  PubMed  PubMed Central  Google Scholar 

Finch, A. P., Meregaglia, M., Ciani, O., Roudijk, B., & Jommi, C. (2022). An EQ-5D-5L value set for Italy using videoconferencing interviews and feasibility of a new mode of administration. Social Science & Medicine (1982), 292, 114519. https://doi.org/10.1016/j.socscimed.2021.114519

Article  Google Scholar 

Miguel, R. T. D., Rivera, A. S., Cheng, K. J. G., Rand, K., Purba, F. D., Luo, N., Zarsuelo, M. A., Genuino-Marfori, A. J., Florentino-Fariñas, I., Guerrero, A. M., & Lam, H. Y. (2022). Estimating the EQ-5D-5L value set for the Philippines. Quality of Life Research, 31(9), 2763–2774. https://doi.org/10.1007/s11136-022-03143-w

Article  PubMed  PubMed Central  Google Scholar 

Olariu, E., Mohammed, W., Oluboyede, Y., Caplescu, R., Niculescu-Aron, I. G., Paveliu, M. S., & Vale, L. (2023). EQ-5D-5L: A value set for Romania. The European Journal of Health Economics, 24(3), 399–412. https://doi.org/10.1007/s10198-022-01481-7

Article  PubMed  Google Scholar 

Sun, S., Chuang, L. H., Sahlén, K. G., Lindholm, L., & Norström, F. (2022). Estimating a social value set for EQ-5D-5L in Sweden. Health and Quality of Life Outcomes, 20(1), 167. https://doi.org/10.1186/s12955-022-02083-w

Article  PubMed  PubMed Central  Google Scholar 

Afshari, S., Daroudi, R., Goudarzi, R., Mahboub-Ahari, A., Yaseri, M., Sari, A. A., Ameri, H., Bahariniya, S., Oliaei-Manesh, A., Kalavani, K., Zare, Z., Hasannezhad, E., Mirzaei, M., & Amiri, Z. (2023). A national survey of Iranian general population to estimate a value set for the EQ-5D-5L. Quality of Life Research, 32(7), 2079–2087. https://doi.org/10.1007/s11136-023-03378-1

Article  PubMed  Google Scholar 

Norman, R., Mulhern, B., Lancsar, E., Lorgelly, P., Ratcliffe, J., Street, D., & Viney, R. (2023). The Use of a Discrete Choice Experiment Including both Duration and Dead for the development of an EQ-5D-5L value set for Australia. Pharmacoeconomics, 41(4), 427–438. https://doi.org/10.1007/s40273-023-01243-0

Article  PubMed  PubMed Central  Google Scholar 

Prevolnik Rupel, V., & Ogorevc, M. (2023). EQ-5D-5L value set for Slovenia. Pharmacoeconomics, 41(11), 1515–1524. https://doi.org/10.1007/s40273-023-01280-9

Article  PubMed  PubMed Central  Google Scholar 

Al-Jedai, A., Almudaiheem, H., Al-Salamah, T., Aldosari, M., Almutairi, A. R., Almogbel, Y., AlRuthia, Y., Althemery, A. U., Alluhidan, M., Roudijk, B., Purba, F. D., & Awad, N. (2024). Valuation of EQ-5D-5L in the Kingdom of Saudi Arabia: A National Representative Study. Value In Health : The Journal of the International Society for Pharmacoeconomics and Outcomes Research, 27(5), 552–561. https://doi.org/10.1016/j.jval.2024.01.017. O’jeil.

Article  PubMed  Google Scholar 

Bailey, H., Jonker, M. F., Pullenayegum, E., Rencz, F., & Roudijk, B. (2024). The EQ-5D-5L valuation study for Trinidad and Tobago. Health and Quality of Life Outcomes, 22(1), 51. https://doi.org/10.1186/s12955-024-02266-7

Article  PubMed  PubMed Central  Google Scholar 

Addo, R., Mulhern, B., Norman, R., Owusu, R., Viney, R., & Nonvignon, J. (2024). An EQ-5D-5L value set for Ghana using an adapted EuroQol Valuation Technology Protocol. Value Health Reg Issues, 45, 101045. https://doi.org/10.1016/j.vhri.2024.101045. Advance online publication.

Article  PubMed  Google Scholar 

Stolk, E., Ludwig, K., Rand, K., van Hout, B., & Ramos-Goñi, J. M. (2019). Overview, update, and lessons learned from the international EQ-5D-5L valuation work: Version 2 of the EQ-5D-5L valuation protocol. Value in Health, 22(1), 23–30. https://doi.org/10.1016/j.jval.2018.05.010

Article  PubMed  Google Scholar 

Hansen, T. M., Helland, Y., Augestad, L. A., Rand, K., Stavem, K., & Garratt, A. (2020). Elicitation of Norwegian EQ-5D-5L values for hypothetical and experience-based health states based on the EuroQol Valuation Technology (EQ-VT) protocol. British Medical Journal Open, 10(6), e034683. https://doi.org/10.1136/bmjopen-2019-034683

Article  Google Scholar 

Dolan, P. (1997). Modeling valuations for EuroQol health states. Medical Care, 35(11), 1095–1108. https://doi.org/10.1097/00005650-199711000-00002

Article  CAS  PubMed  Google Scholar 

van Hout, B., Janssen, M. F., Feng, Y. S., Kohlmann, T., Busschbach, J., Golicki, D., Lloyd, A., Scalone, L., Kind, P., & Pickard, A. S. (2012). Interim scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L value sets. Value In Health : The Journal of the International Society for Pharmacoeconomics and Outcomes Research, 15(5), 708–715. https://doi.org/10.1016/j.jval.2012.02

Article  PubMed  Google Scholar 

Xie, F., Pickard, A. S., Krabbe, P. F., Revicki, D., Viney, R., Devlin, N., & Feeny, D. (2015). A checklist for reporting valuation studies of Multi-attribute Utility-Based instruments (CREATE). Pharmacoeconomics, 33(8), 867–877. https://doi.org/10.1007/s40273-015-0292-9

Article  PubMed  PubMed Central  Google Scholar 

Oppe, M., Devlin, N. J., van Hout, B., Krabbe, P. F., & de Charro, F. (2014). A program of methodological research to arrive at the new international EQ-5D-5L valuation protocol. Value in Health, 17(4), 445–453. https://doi.org/10.1016/j.jval.2014.04.002

Article  PubMed  Google Scholar 

Purba, F. D., Hunfeld, J. A., Iskandarsyah, A., Fitriana, T. S., Sadarjoen, S. S., Passchier, J., & Busschbach, J. J. (2017). Employing quality control and feedback to the EQ-5D-5L valuation protocol to improve the quality of data collection. Quality of Life Research, 26(5), 1197–1208. https://doi.org/10.1007/s11136-016-1445-9

Article  PubMed  Google Scholar 

Rand-Hendriksen, K., Ramos-Goñi, J. M., Augestad, L. A., & Luo, N. (2017). Less is More: Cross-validation testing of simplified nonlinear regression model specifications for EQ-5D-5L Health State values. Value in Health, 20(7), 945–952. https://doi.org/10.1016/j.jval.2017.03.013

Article  PubMed  Google Scholar 

Ramos-Goñi, J. M., Craig, B., Oppe, M., & van Hout, B. (2016). Combining continuous and dichotomous responses in a hybrid model. EuroQol Research Foundation.

Olmos, A., & Govindasamy, P. (2015). A practical guide for using propensity score weighting. Practical Assessment Research and Evaluation, 20(13). https://doi.org/10.7275/jjtm-r398

Jensen, C. E., Sørensen, S. S., Gudex, C., Jensen, M. B., Pedersen, K. M., & Ehlers, L. H. (2021). The Danish EQ-5D-5L Value Set: A hybrid model using cTTO and DCE Data. Applied Health Economics and Health Policy, 19(4), 579–591. https://doi.org/10.1007/s40258-021-00639-3

Article  PubMed  PubMed Central  Google Scholar 

Pickard, A. S., Law, E. H., Jiang, R., Pullenayegum, E., Shaw, J. W., Xie, F., Oppe, M., Boye, K. S., Chapman, R. H., Gong, C. L., Balch, A., & Busschbach, J. J. V. (2019). United States Valuation of EQ-5D-5L Health States using an International Protocol. Value in Health, 931–941. https://doi.org/10.1016/j.jval.2019.02.009

Jiang, R., Rand, K., Kuharic, M., & Pickard, A. S. (2022). EQ-5D-5L measurement properties are superior to EQ-5D-3L across the continuum of health using US value sets. Health and Quality of Life Outcomes, 20(1), 134. https://doi.org/10.1186/s12955-022-02031-8

Article  PubMed  PubMed Central  Google Scholar 

Garratt, A. M., Hansen, T. M., Augestad, L. A., Rand, K., & Stavem, K. (2022). Norwegian population norms for the EQ-5D-5L: Results from a general population survey. Quality of Life Research, 31(2), 517–526. https://doi.org/10.1007/s11136-021-02938-7

Article  PubMed  Google Scholar 

Versteegh, M. M., Vermeulen, K. M., Evers, S. M. A. A., de Wit, G. A., Prenger, R., & Stolk, E. A. (2016). Dutch tariff for the five-level version of EQ-5D. Value in Health, 16(19), 343–352. https://doi.org/10.1016/j.jval.2016.01.003

Article  Google Scholar 

Ramos-Goñi, J. M., Craig, B. M., Oppe, M., Ramallo-Fariña, Y., Pinto-Prades, J. L., Luo, N., & Rivero-Arias, O. (2018). Handling data quality issues to estimate the Spanish EQ-5D-5L value set using a hybrid interval regression approach. Value in Health, 21(5), 596–604. https://doi.org/10.1016/j.jval.2017.10.023

Article